|
Seminars / Meetings
Seminars organized by the
Department of Toxicology
2010
05.02.2010
Dr. Carol Stocking
Molekulare Pathologie, Hamburg
"Activated FLT3 Receptor Tyrosine Kinase
in Acute Leukemia"
2009
18.12.2009
PD Dr. Franz Rödel
Molekulare Strahlenbiologie, Frankfurt
"The inhibitor of apoptosis protein survivin: from the
molecular basis to the clinical application"
04.12.2009
Prof. Dr. Charlotte Esser
Institut für umweltmedizinische Forschung,
Universität Düsseldorf
"Environment and Skin Immunology ? The role of
the aryl hydrocarbon receptor"
27.11.2009
Prof. Dr. Andrew Collins
***
Department of
Nutrition, University of Oslo
"Measuring DNA damage and repair with the comet
assay; recent developments"
06.11.2009
Prof. Dr. Peter Angel
Deutsches Krebsforschungszentrum Heidelberg
"Transcription factor AP-1: multi-facet regulator of genetic
programs controlling tissue remodeling, inflammation and
cancer"
30.10.2009
Dr. rer. nat. Andreas Czich
Sanofi-Aventis Deutschland GmbH
R&D Drug Safety Evaluation FFM
"Genotoxizitätsprüfung in der Industrie: Strategien und
Bedürfnisse im Hinblick auf ein sich veränderndes
regulatorisches Umfeld"
17.07.2009
Prof. Dr. Pablo Steinberg
Institut für
Lebensmitteltoxikologie und Chemische Analytik,
Hannover
"Molecular
mechanisms in experimental and human
colon cancer development"
03.07.2009 Dr.
Niels de Wind
Department of Toxicogenetics
Leiden University Medical
Center
Netherlands
"Mutatis
mutandis: roles of mutagenic translesion
synthesis in
fitness and disease"
12.06.2009 Univ.-Prof.
Dr. med. Norbert Gretz
Zentrum für Medizinische
Forschung
Medizinische Fakultät
Mannheim
"Gene
and miRNA profiling: a structured approach"
27.03.2009
Dr. Eugenia Dogliotti
Unit of Molecular Epidemiology
Istituto Superiore di Sanita Rom
Oxidative DNA damage repair in
proliferating and terminally differentiated
cells: mechanisms and biological
relevance
25.01.2009
Dr. Thomas Radimerski
Novartis Institutes for BioMedical
Research Basel
Oncology Research
Novartis Pharma AG, Basel, Schweiz
JAK2 V617F: A novel molecular
target for chronic
myeloproliferative disorders
2008
19.12.2008
Dr. Grigory Dianov
Gray Institute, Oxford, UK
Regulation of base excision repair
proteins
in response to DNA damage
05.12.2008
Dr. Anamaria Brozovic
R. Boskovic Institute Zagreb
Cisplatin 40 years in clinical
use and still a
matter of investigation
28.11.2008
Prof Dr. Michael Weller
Neurologische Klinik, Universitätsspital Zürich
Novel strategies to overcome
chemo- and
radioresistance in glioblastoma
24.10.2008
Jan Vondracek
Cellular and Molecular Toxicology Group
Institute of Biophysics ASCR
Brno, Czech Republic
The interactions of proinflammatory cytokines
and the AhR-a differential
regulation of
xenobiotic metabolizing enzymes
and cell
proliferation in a rat liver
epithelial cell model
11.07.2008
Dr. J. Pablo Radicella
Institut de Radiobiologie Cellulaire et
Moleculaire
Commissariat a l Energie Atomique
Fontenay-aux-Roses, Frankreich
The ups and downs of the base
excision repair
responses to oxidative stress
04.07.2008
Dr. Fritz Wosegien
Labor Limbach, Heidelberg
Gezielte Chemotherapie, ist es Realität?
16.05.2008
Prof. Dr. Alain Sarasin
CNRS, Paris, France
DNA repair pathways and risk of
metastatis in melanoma patients: A
new hyothesis on metastasis
development
25.04.2008
Prof. Dr. Gerhard Eisenbrand
Institut für Lebensmittelchemie und
Umwelttoxikologie der
Universität Kaiserslautern
Struktur-Wirkung von Antitumor-
wirkstoffen mit Ursprung in der
traditionellen Chinesischen Medizin
18.04.2008
Dr. Harald Genth
Medizinische Hochschule Hannover,
Institut für Toxikologie
The low molecular weight GTP-binding
protein RhoB limiting the
proliferation
of polypoid cells
04.04.2008
Prof. Dr. Sabine Mai
Manitoba Institute of Cell Biology
CancerCare Manitoba, Winnipeg, Canada
c-Myc-dependent genomic
instability
22.02.2008
Dr.
Christel Herold-Mende
Neurochirurgische Universitätsklinik
Sektion Neurochirurgische Forschung
Heidelberg
Tumor stem cells in gliomas: Clinical impact
and therapeutical strategies
|
